Skip to main content Back to Top
Advertisement

6/18/2021

Guanfacine Hydrochloride Tablets

Products Affected - Description

    • Guanfacine hydrochloride oral immediate release tablet, Mylan, 1 mg, bottle, 100 count, NDC 00378-1160-01
    • Guanfacine hydrochloride oral immediate release tablet, Mylan, 2 mg, bottle, 100 count, NDC 00378-1190-01
    • Guanfacine hydrochloride oral immediate release tablet, Teva, 1 mg, bottle, 100 count, NDC 00591-0444-01
    • Guanfacine hydrochloride oral immediate release tablet, Teva, 2 mg, bottle, 100 count, NDC 00591-0453-01

Reason for the Shortage

    • Amneal has guanfacine tablets available.
    • Mylan did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.

Available Products

    • Guanfacine hydrochloride oral immediate release tablet, Amneal, 1 mg, bottle, 100 count, NDC 65162-0711-10
    • Guanfacine hydrochloride oral immediate release tablet, Amneal, 2 mg, bottle, 100 count, NDC 65162-0713-10

Estimated Resupply Dates

    • Mylan has guanfacine 1 mg and 2 mg tablets in 100 count bottles on back order and the company cannot estimate a release date.
    • Teva has guanfacine 1 mg tablets on back order and the company estimates a release date of early-August 2021. The 1 mg tablets are available with short expiration dating (November 2021). The 2 mg tablets are on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated June 18, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 4, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.